Investigating blood clotting changes in patients with COVID-19
Not Applicable
Completed
- Conditions
- Thrombosis in patients with COVID-19 (SARS-CoV-2 infection)Circulatory System
- Registration Number
- ISRCTN64783542
- Lead Sponsor
- Oxford University Hospitals NHS Trust
- Brief Summary
2020 Results article in https://pubmed.ncbi.nlm.nih.gov/33351117/ (added 13/07/2021)
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 303
Inclusion Criteria
1. Adult (aged 18 years or older)
2. Admitted to Oxford University Hospitals NHS Foundation Trust with confirmed or high clinical suspicion of COVID-19
Exclusion Criteria
Does not meet inclusion criteria
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie SARS-CoV-2-induced coagulopathy in ISRCTN64783542 observational study?
How do thrombotic outcomes in ISRCTN64783542 compare with standard anticoagulant therapies for hospitalized COVID-19 patients?
Which biomarkers for hypercoagulability were validated in ISRCTN64783542 to predict severe thrombosis in SARS-CoV-2 infections?
What adverse events related to thrombotic complications were observed in ISRCTN64783542 and how were they managed?
How do findings from ISRCTN64783542 align with anticoagulant strategies in competing trials for managing COVID-19-related thrombosis?